Valencia Technologies
Valencia Technologies, based in Valencia, California, specializes in neuromodulation technology for bladder dysfunction, offering the FDA-approved eCoin device for Urge Urinary Incontinence (UUI).
Headquarters
Valencia Technologies is headquartered in Valencia, California. The location serves as the central hub for research, development, and operations for the company’s innovative neuromodulation technologies.
Specialization in Neuromodulation Technology
Valencia Technologies specializes in neuromodulation technology, particularly targeting bladder dysfunction. Their primary product, the eCoin, is designed to address Urge Urinary Incontinence (UUI) through advanced neuromodulation techniques.
eCoin Device for Urge Urinary Incontinence
Valencia Technologies offers the eCoin, an FDA approved implantable neuromodulation device aimed at treating Urge Urinary Incontinence (UUI). The device provides automatic stimulation of the tibial nerve to control bladder function. The implantation procedure is minimally invasive, requiring only local anesthetic. Unlike other devices, the eCoin doesn't need lead wires, external remotes, or regular recharging.
FDA Approval
The eCoin device from Valencia Technologies has received FDA approval. This endorsement signifies that the eCoin meets all safety and efficacy standards set by the Food and Drug Administration, further validating its use for treating Urge Urinary Incontinence (UUI).